Clinical Evaluation of Medical Devices

Masuu Global Solutions is your trusted partner for conducting Clinical Evaluation across all classes of medical devices. We develop robust Clinical Evaluation Plans (CEP), execute reproducible Systematic Literature Reviews (SLRs), and author high quality Clinical Evaluation Reports (CERs) that clearly demonstrate safety, performance, and compliance with EU MDR 2017/745—fully prepared for Notified Body scrutiny.

Clinical Evaluation of Medical Devices – Overview

Masuu delivers end to end Clinical Evaluation services using rigorous methodologies, transparent State of the Art (SOTA) justification, and lifecycle based maintenance. From CEP development to CER writing, PMCF planning, and continuous updates, we align every element of your evidence package with General Safety & Performance Requirements (GSPRs) and MDR expectations. Our approach ensures your submissions are scientifically sound, fully traceable, and Notified Body–ready.

Masuu’s Tailored Clinical Evaluation Services

  1. Clinical Evaluation Gap Analysis
  2. We identify gaps in your existing CERs relative to MDR expectations and GSPRs.
    Our assessment includes:
    • Methodological alignment
    • Equivalence strategies
    • Benefit–risk justification
    • State of the art accuracy
    • Traceability and document consistency

    Masuu delivers a prioritized remediation roadmap with clear evidence recommendations and NB ready rationales to prevent non conformities and accelerate approvals.

  3. Tailored Literature Strategy & Systematic Literature Review (SLR)
  4. Masuu develops customized literature review strategies:
    • Multi database searches
    • Dual screening workflow
    • Critical appraisal using validated criteria
    • Structured evidence synthesis
    • PRISMA style documentation
    • Full traceability matrices

    Our SLR outputs establish a defensible State of the Art baseline and directly strengthen the CER.

  5. SME Support for Non Conformity (NC) Review
  6. If Notified Bodies raise NCs, Masuu mobilizes senior clinical writers and regulatory experts to:
    • Interpret NB findings
    • Refine equivalence arguments
    • Strengthen benefit–risk justifications
    • Improve appraisal and SLR methodology
    • Prepare persuasive, audit ready NB responses

    This reduces review cycles and speeds up CER approval.

  7. SOP Development for Clinical Evaluation
  8. Masuu designs MDR aligned SOPs covering:
    • CEP development
    • Literature search and appraisal
    • Equivalence assessment
    • Benefit–risk evaluation
    • Traceability requirements

    Our SOPs establish consistent, repeatable workflows that withstand audits and enable high quality CER output across teams.

  9. Annual CER Maintenance
  10. We manage periodic CER updates by integrating:
    • PMS trends
    • Vigilance and incident reports
    • PMCF findings
    • New clinical and scientific literature
    • Market and regulatory changes

    Your CER stays up to date, traceable, and audit ready across the EU MDR lifecycle.

  11. Full Time Employee (FTE) Support
  12. Masuu deploys dedicated FTE resources to strengthen your internal capabilities with:
    • CER writing specialists
    • Clinical evaluation SMEs
    • SLR experts
    • PMCF strategists

    Our specialists bring Notified Body–facing experience and ensure high quality submissions with scalable capacity.

  13. Procedural Training on Clinical Evaluation
  14. We offer hands on training tailored to your team’s needs:
    • MDR clinical evaluation fundamentals
    • Literature search methodology
    • Equivalence and benefit–risk justification
    • SSCP/PSUR integration
    • Best practices for CER writing

    Your teams gain the skills necessary to produce consistent, compliant, and audit ready evaluations.

    Masuu’s Clinical Evaluation Deliverables

    Clinical Evaluation Plan (CEP)

    We develop device specific CEPs defining:
    • Intended purpose & indications
    • Evaluation objectives & claims
    • Acceptance criteria
    • Equivalence strategy
    • SLR methodology
    • Traceability mapping

    Systematic Literature Review (SLR)

    Masuu conducts:
    • Multi database searches
    • Dual screening
    • Critical appraisal
    • Evidence grading
    • Structured synthesis

    All delivered with PRISMA documentation and traceability matrices.

    Clinical Evaluation Report (CER)

    Our CERs include:
    • Device description & clinical background
    • State of the Art
    • Appraisal & analysis of clinical data
    • Comprehensive benefit–risk evaluation
    • Residual risk justification
    • PMCF linkage
    • GSPR mapping

    We also manage ongoing CER updates aligned with PMS and PSUR cycles.

    Summary of Safety and Clinical Performance (SSCP)

    We prepare clear, compliant SSCPs with:
    • Device purpose & intended use
    • Clinical performance summary
    • Benefit–risk profile
    • Residual risks
    • Evidence traceability to CER/PMS/PMCF

    Frequently Asked Questions

    A Clinical Evaluation is a documented process used to demonstrate that a medical device meets applicable safety, performance, and clinical benefit requirements under EU MDR 2017/745. It evaluates relevant clinical data, the current State of the Art, benefit–risk considerations, and supporting evidence to establish conformity with applicable General Safety and Performance Requirements.

    A Clinical Evaluation Plan should define the device’s intended purpose and indications, evaluation objectives, clinical claims, acceptance criteria, evidence strategy, equivalence approach, literature search methodology, and traceability requirements. The CEP establishes the methodology for the evaluation and provides the framework for developing a consistent and defensible Clinical Evaluation Report.

    A Clinical Evaluation Plan (CEP) defines how the clinical evaluation will be conducted, including its objectives, methodology, evidence requirements, and acceptance criteria. A Clinical Evaluation Report (CER) documents the results of that evaluation, including clinical data analysis, State of the Art assessment, benefit–risk evaluation, conclusions, and supporting evidence.

    Literature evidence is an important component of a clinical evaluation, particularly when establishing the State of the Art and assessing available clinical evidence. A systematic literature review should use a defined search strategy, appropriate databases, screening and appraisal methods, evidence synthesis, and traceability. The methodology should be appropriate to the device and evaluation objectives.

    A systematic literature review for an EU MDR CER should begin with a defined research question and search strategy. Relevant databases are searched using documented criteria, publications are screened and critically appraised, and evidence is synthesized against the evaluation objectives. Clear documentation and traceability help demonstrate that the literature methodology is reproducible and scientifically justified.

    The required evidence depends on the device, intended purpose, claims, risks, technology, and available clinical data. A CER may consider clinical investigations, literature, post-market data, PMS information, PMCF findings, and other relevant evidence. The evidence should adequately support safety, performance, clinical benefit, and the device’s overall benefit–risk determination.

    Notified Body findings should be addressed by identifying the specific methodological or evidentiary gap and providing a documented response supported by appropriate evidence. Common areas requiring strengthening include equivalence arguments, State of the Art justification, literature appraisal, benefit–risk assessment, and traceability. Responses should directly address each finding and maintain consistency across the clinical documentation.

    Equivalence should be supported through a structured comparison of relevant device characteristics, intended purpose, technical features, and clinical considerations. The evaluation should demonstrate that the available evidence is appropriate for supporting the conclusions drawn from the equivalent device. The justification must be sufficiently detailed, traceable, and consistent with the applicable EU MDR clinical evaluation requirements.

    A CER should be maintained throughout the device lifecycle rather than treated as a one-time submission document. Updates should consider new clinical and scientific literature, PMS trends, vigilance information, PMCF findings, emerging risks, and relevant regulatory or market developments. The update frequency should reflect the device’s risk profile, evidence requirements, and applicable post-market processes.

    PMCF generates post-market clinical evidence that can provide additional information about a device’s safety, performance, and clinical benefit during its lifecycle. Relevant PMCF findings should be incorporated into the clinical evaluation and benefit–risk assessment. This helps maintain the CER as a current evidence document and supports ongoing conformity with EU MDR requirements.

Book a Demo